NEW YORK, March 3, 2010 /PRNewswire/ -- Kantar Health, a leading healthcare-focused global consultancy and marketing insights company, has appointed Ceri Thomas as Head of Global Marketing. In this role, he will develop and implement Kantar Health's global marketing strategies. Mr. Thomas is based in Kantar Health's London-area office.
Ceri's global experience and perspective, combined with client-side experience and deep knowledge of our offers and processes, will be a great addition to Kantar Health's Marketing team and will enable us to continue to develop and better communicate to our clients our value proposition focused on supporting their growth strategies, said Richard Martin, Kantar Health's CEO of Global Practices, Americas.
For the past two years, Mr. Thomas has led the Global Client Accounts team for TNS Healthcare, now Kantar Health. Before joining Kantar Health, he spent 18 years at Pfizer, most recently as Director Team Leader, European Brand Analytics, leading an international team delivering market research and competitive intelligence support to European brand teams and senior leadership.
Mr. Thomas began his career in the pharmaceutical industry at Beecham Pharmaceuticals after performing post-graduate work in microbiology at the John Radcliffe Hospital in Oxford.
About Kantar Health
Kantar Health is a leading healthcare-focused global consultancy, specializing in portfolio optimization, market access, safety and outcomes, and brand and customer insights. Formed by uniting Consumer Health Sciences, MattsonJack, TNS Healthcare and Ziment, it is the next-generation decision support partner to the pharmaceutical and biotech industries, delivering evidence-based guidance to support clients' global and local success.
With 40+ offices throughout the Americas, Europe, Asia-Pacific, the Middle East and Africa, Kantar Health provides the broadest global footprint, coupled with the strongest local knowledge to help drive clients' maximum performance in every geography. Market-leading solutions ensure optimal decisions and actions across the brand life cycle, from assessing opportunities and sizing markets...to developing products and building access strategies...to positioning brands and creating messaging...to managing stakeholder relationships and monitoring treatment outcomes.
SOURCE: Kantar Health
CONTACT: Paula Paradise, Vice President of Global Marketing, KantarHealth, paula.paradise@kantarhealth.com, +1-484-442-1431
Comments